Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Certara Inc (CERT)

Certara Inc (CERT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Certara Inc 4 Radnor Corporate Center Suite 350 Radnor PA 19087 USA

www.certara.com Employees: 1,546 P: 415-237-8272

Sector:

Medical

Description:

Certara Inc. provides medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara Inc. is based in NJ, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,103,762
Enterprise Value, $K 1,220,012
Shares Outstanding, K 159,273
Float, K 155,562
% Float 97.67%
Short Interest, K 21,557
Short Float 13.54%
Days to Cover 10.27
Short Volume Ratio 0.52
% of Insider Shareholders 2.33%
% of Institutional Shareholders 73.96%

Financials:

Annual Sales, $ 385,150 K
Annual Net Income, $ -12,050 K
Last Quarter Sales, $ 104,620 K
Last Quarter Net Income, $ 1,530 K
EBIT, $ 82,280 K
EBITDA, $ 151,350 K

Growth:

1-Year Return -51.61%
3-Year Return -63.96%
5-Year Return -80.66%
5-Year Revenue Growth 84.72%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.14 on 11/06/25
Next Earnings Date 02/26/26 [BMO]
Earnings Per Share ttm 0.34
EPS Growth vs. Prev Qtr 200.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CERT Ratios

Ratio
Price/Earnings ttm 20.59
Price/Earnings forward 20.19
Price/Earnings to Growth N/A
Return-on-Equity % 5.18%
Return-on-Assets % 3.56%
Profit Margin % -3.13%
Debt/Equity 0.28
Price/Sales 2.69
Price/Cash Flow 9.73
Price/Book 1.06
Book Value/Share 6.63
Interest Coverage -0.20
60-Month Beta 1.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar